High Vista Strategies LLC Charles River Laboratories International, Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$102.37 - $117.25 $327,584 - $375,200	-3,200 Closed	0 $0
Q1 2018 May 15, 2018	SELL	$98.19 - $115.2 $29,457 - $34,560	-300 Reduced 8.57%	3,200 $342,000
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $120,516 - $141,708	-1,200 Reduced 25.53%	3,500 $383,000
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $454,584 - $513,522	4,700	4,700 $508,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.